Breaking news on headache and migraine
Head Start For Migraine Sufferers published
Fri, 03 Sep 2010 02:00:00 PDT
Psychological migraine treatment gives sufferers a confidence boost in their ability to self-manage their symptoms. For severe migraine sufferers, psychological treatments build on the benefits of drug therapy, according to a new study by Elizabeth Seng and Dr. Kenneth Holroyd from Ohio University in the US...
Botox Maker Allergan Agrees To Pay $600 Million And Pleads Guilty To Misdemeanor published
Wed, 01 Sep 2010 11:00:00 PDT
Allergan Inc., the makers of BOTOX (onabotulinumtoxinA) announced that it has agreed to pay US $600 million and to plead guilty to misdemeanor, thus reaching a resolution with the DOJ (US Department of Justice) regarding a previously reported Government investigation into the company's past sales and marketing practices related to specific therapeutic uses of BOTOX...
Genetic Link To Migraine Found, In DNA Variant On Chromosome 8 published
Mon, 30 Aug 2010 10:00:00 PDT
Scientists have identified the first genetic risk factor linked to a common type of migraine after examining the genetic data of over 50,000 individuals. The investigators say that this breakthrough gives them new insights into migraine triggers, which will hopefully lead to novel therapies to prevent episodes of migraine...
Recurrent Teen Headaches Linked To Smoking, Overweight And Physical Inactivity published
Thu, 19 Aug 2010 08:00:00 PDT
Teenagers who regularly have headaches may find that their problem is linked to overweight, smoking and/or lack of physical exercise, according to an article published in the medical journal Neurology. The authors found that teenagers with all three factors - those who were overweight, smoked and did very little exercise - were 3...
Headaches In Teens Tied To Overweight, Smoking And Lack Of Exercise published
Thu, 19 Aug 2010 04:00:00 PDT
Teens who are overweight, get little exercise or who smoke may be more likely to have frequent headaches and migraines than teens with none of these factors, according to a study published in the August 18, 2010, online issue of Neurology®, the medical journal of the American Academy of Neurology. Teens with all three of the negative lifestyle factors were 3...
Nautilus Neurosciences Announces U.S. Launch Of CAMBIA(TM) (Diclofenac Potassium For Oral Solution) For The Treatment Of Migraine published
Sat, 07 Aug 2010 02:00:00 PDT
Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company headquartered in New Jersey, announced that CAMBIA(TM) (diclofenac potassium for oral solution) is now available in the United States for the acute treatment of migraine with or without aura. CAMBIA was approved by the U.S. Food and Drug Administration in June 2009...
BOTOX(R) Receives First Authorisation In UK As Preventative Treatment In Chronic Migraine published
Mon, 12 Jul 2010 04:00:00 PDT
Allergan has today announced that BOTOX® (botulinum toxin type A) has been licensed by the MHRA in the UK for the prophylaxis of headaches in adults who have chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine)1...
HeadCoolieTM Adjustable, Reusable Head Wrap Provides Non-Chemical, Non-Prescription Therapeutic Relief For Fever Symptoms And Headaches published
Fri, 09 Jul 2010 02:00:00 PDT
American Diversified Medical Corporation, a majority owned subsidiary of ThermaFreeze Products Corporation (PINKSHEETS: TZPC), unveiled its newest product line, the HeadCoolie™...
A Simple Massage Is Proven To Relieve Psychological And Physiological State Of Patients With Chronic Tension Headache published
Fri, 09 Jul 2010 02:00:00 PDT
Researchers at the University of Granada -in collaboration with the Clinical Hospital San Cecilio and the University Rey Juan Carlos- have proven that the psychological and physiological state of patients with tension headache improves within 24 hours after receiving a 30-minute massage. As researchers explained, tension headaches have an increasing incidence in the population...
GlaxoSmithKline And XenoPort Report Top-Line Phase 2b Results For GSK1838262/XP13512 As A Prophylactic Treatment For Migraine Headache published
Fri, 09 Jul 2010 01:00:00 PDT
GlaxoSmithKline (NYSE:GSK) and XenoPort, Inc. (Nasdaq:XNPT) announced today that GSK1838262/XP13512 (gabapentin enacarbil) did not demonstrate a statistically significant improvement compared to placebo as a prophylactic treatment for migraine headaches...
REM Sleep Deprivation Plays A Role In Chronic Migraine published
Thu, 24 Jun 2010 00:00:00 PDT
Reporting at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week, new research shows that sleep deprivation leads to changes in the levels of key proteins that facilitate events involved in the underlying pathology of migraine. Paul L. Dunham, Ph.D...
Migraine: Abnormal Brain Activity Not Restricted To Attacks published
Thu, 24 Jun 2010 00:00:00 PDT
Typically, migraine is considered to be an episodic disorder with discrete attacks of headache. But new research by Dr. Till Sprenger and his team from UCSF Headache Group and Technische Universitat Munchen found increased network activity -- stronger functional connectivity -- bilaterally in the visual, auditory and sensorimotor network in migraineurs...
Soldiers With Migraine Endure Poor Sleep Quality published
Thu, 24 Jun 2010 00:00:00 PDT
Some 19 percent of soldiers returning from Iraq have migraine and migraine is suspected in another 17 percent. While prevalence of migraine among the U.S. military is well documented , little is known about sleep quality in soldiers with chronic headaches including post-traumatic headache and migraine...
Migraine Sufferers Who Experienced Childhood Abuse Have Greater Risk Of Cardiovascular Disease published
Thu, 24 Jun 2010 00:00:00 PDT
Migraine sufferers who experienced abuse and neglect as children have a greater risk of cardiovascular (CV) disease including stroke and myocardial infarction (MI) among others, say scientists presenting data at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week...
Stigma Of Migraine Is Significant; Worse For Those With Chronic Migraine published
Thu, 24 Jun 2010 00:00:00 PDT
Researchers looking for the first time at how migraine sufferers experience the stigmatizing effects of their disease show that chronic migraine sufferers experience worse stigma than episodic migraine sufferers and more than those with other neurological diseases including stroke, epilepsy and MS...
Link Between Adverse Childhood Experiences And Frequent Headache In Adults published
Thu, 24 Jun 2010 00:00:00 PDT
Children who experience maltreatment such as emotional, physical and sexual abuse are more likely to experience frequent headaches, including chronic migraine, as adults, say scientists presenting data at the American Headache Society's 52nd Annual Scientific Meeting in Los Angeles this week...
Oral Efficacy Of Lasmiditan (COL-144), A Selective 5-HT1F Receptor Agonist, In The Treatment Of Acute Migraine Attacks - Study Data published
Thu, 10 Jun 2010 03:00:00 PDT
CoLucid Pharmaceuticals, Inc...
Sitting In Front Of A Screen Associated With Physical Complaints In Teenagers published
Wed, 09 Jun 2010 03:00:00 PDT
The amount of time teenagers spend in front of TV screens and monitors has been associated with physical complaints. A large study of more than 30,000 Nordic teenagers published in the open access journal BMC Public Health has shown that TV viewing, computer use and computer gaming (screen time) were consistently associated with back pain and recurrent headaches...
Treatment For Headaches And Dizziness Caused By Traumatic Brain Injury Appears Promising, Study Says published
Wed, 09 Jun 2010 00:00:00 PDT
A recent retrospective study by four Michigan physicians shows strong evidence that symptoms of headache, dizziness and anxiety in some patients with traumatic brain injury potentially could be alleviated or even eliminated with specialized eyeglass lenses containing prisms. The paper was published in the April 2010 issue of Physical Medicine and Rehabilitation...
Modifiable Risk Factors For Headaches And Migraines In Teens published
Mon, 07 Jun 2010 02:00:00 PDT
A novel study by German researchers reported that alcohol consumption and cigarette smoking were associated with increased migraines and tension-type headaches (TTH) in high school students. Coffee drinking and physical inactivity were associated specifically with migraines...
Trigemina, Inc. Reports Preliminary Results For Phase IIa Clinical Trial In Chronic Daily Headache published
Wed, 26 May 2010 23:00:00 PDT
Trigemina, Inc. (TI), a Mountain View based privately-held biopharmaceutical company, reports positive results from a time-based interim analysis of its Phase IIa clinical trial in Chronic Daily Headache (CDH). The trial is a collaborative effort between Trigemina and Dr. Egilius Spierings of MedVadis Research Corporation located outside of Boston...
In The Dentist's Chair A Sniff Of Local Anesthetic Could Replace The Needle published
Fri, 14 May 2010 02:00:00 PDT
Modern dentistry has eliminated much of the "ouch!" from getting a shot of local anesthetic. Now a new discovery may replace the needle used to give local anesthetic in the dentist's chair for many procedures...
Ortho-McNeil-Janssen Pharmaceuticals, Inc. Resolves Investigation Of Past TOPAMAX(R) Marketing And Promotional Activities published
Fri, 30 Apr 2010 13:00:00 PDT
Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI) announced an agreement with the U.S. Attorney's Office for the District of Massachusetts, the U.S. Department of Justice, and other federal agencies to resolve a previously reported government investigation of past U.S...
MAP Pharmaceuticals Announces Potential Of LEVADEX(TM) To Treat Patients With Menstrual Migraine And With Allodynia During Migraine published
Thu, 15 Apr 2010 03:00:00 PDT
MAP Pharmaceuticals, Inc. (Nasdaq: MAPP) announced additional post-hoc analyses of data from the FREEDOM-301 Phase 3 trial of its investigational LEVADEX™ orally inhaled migraine therapy showing efficacy in two difficult to treat patient subpopulations, menstrual migraine and migraine with allodynia...
Aspirin Effective For Migraine Relief, Study published
Wed, 14 Apr 2010 03:00:00 PDT
A single dose of 900-1000 mg aspirin can substantially reduce migraine headache pain within two hours, for more than half of people who take it. It also reduces any associated nausea, vomiting, and sensitivity to light or sound (photophobia or phonophobia)...
)
|
|
